Rate of Conversion from Prodromal Alzheimer's Disease to Alzheimer's Dementia: A Systematic Review of the Literature
Open accessThe DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Abstract
Background: The purpose of this study was to summarize published estimates for conversion from mild cognitive impairment or amnestic mild cognitive impairment to Alzheimer's dementia. We carried out a systematic review of English language publications to identify cohort studies published since January 2006 that reported the risk or rate of conversion. Summary: Thirty-two cohort studies were identified, of which 14 reported annualized conversion rates (ACRs). Conversions over 1 year ranged from 10.2 to 33.6% (5 studies, median: 19.0%), and over 2 years from 9.8 to 36.3% (7 studies, median: 18.6%). ACRs ranged from 7.5 to 16.5% (7 studies, median: 11.0%) per person-year for studies recruiting from clinics, and from 5.4 to 11.5% (7 studies, median: 7.1%) for community samples. Key Message: Extensive variation was observed in conversion rates due to the population sampled, diagnostic criteria, and duration, and because many studies did not account for loss to follow-up.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“About one-third develop dementia due to Alzheimer's within five years.52”
From 2023 Alzheimer's disease facts and figures (2023) · cites this paper as [52]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“About one‐third develop dementia due to Alzheimer's within five years.”
From 2024 Alzheimer's disease facts and figures (2024) · cites this paper as [52]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & the PRISMA Group* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00135 · Cited by 37,554
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2009) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2009.06.005 · Cited by 19,575
Mild Cognitive Impairment: Clinical Characterization and Outcome
Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999) · Archives of Neurology · doi:10.1001/archneur.56.3.303 · Cited by 8,980
Mild cognitive impairment as a diagnostic entity
Petersen, R. C. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01388.x · Cited by 7,864
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155
Winblad, B., Palmer, K., Kivipelto, M., Jelic, V., Fratiglioni, L., Wahlund, L. ‐., Nordberg, A., Bäckman, L., Albert, M., Almkvist, O., et al. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01380.x · Cited by 4,946
Current concepts in mild cognitive impairment
Petersen, R. C., Doody, R., Kurz, A., Mohs, R. C., Morris, J. C., Rabins, P. V., Ritchie, K., Rossor, M., Thal, L., & Winblad, B. (2001) · Archives of Neurology · doi:10.1001/archneur.58.12.1985 · Cited by 4,781
Forecasting the global burden of Alzheimer's disease
Brookmeyer, R., Johnson, E., Ziegler‐Graham, K., & Arrighi, H. M. (2007) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2007.04.381 · Cited by 3,370
Self-citation
Cited by
Items 301–400 of 427
Genadry, F., Kalyani, P., Elgallab, B. M., Brooks, H. J., Blumberger, D., Kumar, S., Mulsant, B. H., Bowie, C., & Rajji, T. (2025) · International Psychogeriatrics · doi:10.1016/j.inpsyc.2025.100116 · Cited by 3
Trinca, V., Anderson, N. D., Fiocco, A. J., Ferland, G., Laurin, D., & Keller, H. (2023) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2023-0211 · Cited by 6
Prognostic Information on Progression to Dementia: Quantification of the Impact on Quality of Life
Vermeulen, R. J., Roudijk, B., Govers, T. M., Rovers, M. M., Rikkert, M. O., & Wijnen, B. F. M. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-231037 · Cited by 4
Cognitive Impairment in the Primary Care Clinic
Womack, C. L., Perkins, A., & Arnold, J. M. (2024) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2024.02.010 · Cited by 4
Nguyen, C. Q. N., Ma, L., Low, Y. L., Tan, E. C. K., Fowler, C. J., Masters, C. L., Jin, L., & Pan, Y. (2024) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12593 · Cited by 10
Eppig, J. S., Werhane, M. L., Edmonds, E. C., Wood, L.-D., Bangen, K. J., Jak, A. J., Thomas, K. R., Wong, C. G., Weigand, A. J., & Bondi, M. W. (2020) · Oxford University Press eBooks · doi:10.1093/oso/9780190634230.003.0004 · Cited by 3
Luo, W., Wen, H., Ge, S., Tang, C., Liu, X., & Lu, L. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.774804 · Cited by 4
Ribeiro, R., dos Santos, A. C. S., Calazans, M., de Oliveira, A. C. P., & Vieira, L. B. (2021) · Nutritional Neuroscience · doi:10.1080/1028415x.2021.1972514 · Cited by 4
“Prevalence studies also indicated that MCI conversion rates to AD are around 10–15% per year [14,15].”
BackgroundKim, W., Choi, M., Han, J., Lee, S. Y., & Ju, Y. J. (2024) · Public Health · doi:10.1016/j.puhe.2024.07.013 · Cited by 2
Arrieta, E., Baz, P. G., & García‐Ribas, G. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1434210 · Cited by 3
Morgan, B. E., Brody, A. A., Chodosh, J., Karlawish, J. H., Ravitch, S. M., Massimo, L. M., & Hodgson, N. A. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70286 · Cited by 3
Zhao, J., Tian, H., Wang, Y., Xu, X., Ma, X., & Fan, L. (2025) · Physiological Measurement · doi:10.1088/1361-6579/ae06ed · Cited by 2
“For instance, the annual conversion rate from mild cognitive impairment (MCI) to dementia ranges from 7.5% to 16.5%, while the conversion rate among cognitively normal elderly individuals is only 1%–2% (Li et al 2012, Ward et al 2013).”
InfluentialNasrallah, I. M., Polacek, C., Frech, F. H., Tariot, P. N., Vawter, J., Zabar, Y., Divers, C., Shang, W. Y., Geldmacher, D., Towman, M., et al. (2025) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.70162 · Cited by 3
Gurja, J. P., Muthukrishnan, S. P., Tripathi, M., Mehta, N., & Sharma, R. (2022) · Neurology India · doi:10.4103/0028-3886.349605 · Cited by 2
Platero, C. A., Tohka, J., & Strange, B. A. (2023) · Current Alzheimer Research · doi:10.2174/0115672050295317240223162312 · Cited by 3
Deep Learning Based Diagnosis of Mild Cognitive Impairment Using Resting-State Functional MRI
Li, G., Song, Y., Liang, H., Sun, X., Yu, J., Zhai, R., & Liang, M. (2024) · Journal of Medical and Biological Engineering · doi:10.1007/s40846-024-00912-5 · Cited by 2
“A systematic review found that MCI carries a high risk of progression to AD, with an average of 32% of MCI patients developing AD within five years [3].”
Morgan, B. E., Massimo, L. M., Ravitch, S. M., Brody, A. A., Chodosh, J., Karlawish, J. H., & Hodgson, N. A. (2025) · Geriatric Nursing · doi:10.1016/j.gerinurse.2025.01.047 · Cited by 2
Platzbecker, A. L., Gronewold, J., Schramm, S. H., Moebus, S., Stang, A., Schmidt, B., Weimar, C., Jokisch, M., & the Heinz Nixdorf Recall Study Investigative Group (2025) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.70130 · Cited by 4
Wang, Y., Song, Y., Zhang, C., Ren, J., Xue, P., Hou, Y., & Chen, Z. (2025) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-025-03040-5 · Cited by 2
“People with MCI who have cognitive deficits that do not directly affect activities of daily living may progress to AD within a certain period of time and may even return to normal if cognitive abilities do not decline further [5, 6].”
Kitagawa, K., Yoshizawa, H., Toi, S., & Todo, K. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251365629 · Cited by 6
Alsaadi, T. M., Almadani, A., Alrukn, S., Hassan, A., Sarathchandran, P., Shatila, A. O., Szólics, M., Benito, D., İnce, S., & Krieger, D. W. (2025) · Neurology and Therapy · doi:10.1007/s40120-025-00833-8 · Cited by 3
Reactions to a Probable Diagnosis of HIV-Associated Neurocognitive Disorder: A Content Analysis
Vance, D. E., Robinson, J., Walker, T. J., Tende, F., Bradley, B., Diehl, D., McKie, P., & Fazeli, P. L. (2019) · Journal of the Association of Nurses in AIDS Care · doi:10.1097/jnc.0000000000000120 · Cited by 2
Kirch, S., Gorus, E., Brys, C., Cornelis, E., & VRIENDT, P. D. (2018) · European Geriatric Medicine · doi:10.1007/s41999-018-0066-y · Cited by 2
Karimi, H., Marefat, H., Khanbagi, M., Karami, A., & Vahabi, Z. (2021) · Frontiers in biomedical technologies · doi:10.18502/fbt.v8i1.5857 · Cited by 2
Farina, E., Borgnis, F., Scioli, S., d’Arma, A., D’Amico, A., & Saibene, F. L. (2022) · Geriatrics · doi:10.3390/geriatrics7020049 · Cited by 2
Dunstan, D. M., Barvas, E., Guttmann, S., Frusciante, R., Viti, B., Volpini, M., Cannuccia, M., Monaldini, C., Tamagnini, F., Goodfellow, M., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.12.16.628666 · Cited by 2
Mild Cognitive Impairment in Older Adults
Harris, M., Rooker, J. L., & Keilman, L. J. (2023) · Advances in Family Practice Nursing · doi:10.1016/j.yfpn.2023.01.003 · Cited by 1
Farris, T., Ochoa, S. G., Mohammed, M. A., Rajakaruna, H., Tonello, J. M., Kanagasabai, T., Korolkova, O. Y., Shimamoto, A., Ivanova, A. V., & Shanker, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137406 · Cited by 1
“Notably, only 30% of people with MCI progress to an irreversible stage of the disease characterized by severe memory loss and loss of independence [7].”
BackgroundGuo, H., Sun, S., Yang, Y., Ma, R., Wang, C., Zheng, S., Wang, X., Li, G., & Initiative, A. D. N. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240532 · Cited by 2
Du, Y., Zheng, B., Wang, X., Song, T., Liang, D., Petersen, J. D., & Huang, J. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1538665 · Cited by 2
“Around 15% of individuals with MCI progress to dementia within 2 years, with about 32% developing Alzheimer’s-related dementia within 5 years (2, 3).”
Chen, D., Zhang, M., Han, H., Wen, Y., & Yu, H. (2025) · BMC Medical Research Methodology · doi:10.1186/s12874-025-02618-x · Cited by 6
“In addition, the onset of diseases often encompasses various stages, during which patients may experience deterioration as well as subsequent improvement after deterioration [49, 50].”
Development and validation of a model to predict the progression of Alzheimer’s disease
Chu, C., Wang, Y., Huynh, A. L. H., Ng, K. W., Liu, S., Ji, G., Doecke, J. D., Fripp, J., Masters, C. L., Goudey, B., et al. (2025) · Age and Ageing · doi:10.1093/ageing/afaf198 · Cited by 2
“This is well in line with the clinically observed annual MCI-to-AD conversion rate of 10%–15% [5] and provides a well-balanced dataset for training.”
Fonseca, M., Araújo, N., Ruano, L., & Amorim, M. (2025) · Acta Médica Portuguesa · doi:10.20344/amp.23241 · Cited by 1
Vermeulen, R. J., Rikkert, M. O., Handels, R. L. H., Haraldsen, I., Renvall, H., Rossini, P. M., Marra, C., Maestú, F., Rovers, M. M., & Govers, T. M. (2026) · GeroScience · doi:10.1007/s11357-025-02032-7 · Cited by 2
Sayman, C., Toplutaş, E., Aylak, U., Safa, S. S., Savcili, M., Karakuş, A., Ucak, A. D., Hanoğlu, L., Çankaya, Ş., Mardinoğlu, A., et al. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1734828 · Cited by 1
“Longitudinal data suggest that individuals with MCI progress to dementia at a rate of approximately 10 to 15% per year, whereas cognitively healthy seniors progress at a rate of only 1 to 2% per year (Ward et al., 2013).”
Yan, X., Tang, F., & Jin, Y. (2026) · Neurocomputing · doi:10.1016/j.neucom.2026.134662 · Cited by 1
Cognitive Decline in Women: The ZARADEMP Study
Gracia‐García, P., Lobo, E., Santabárbara, J., de la Cámara, C., & López‐Antón, R. (2019) · Springer eBooks · doi:10.1007/978-3-030-13936-0_28 · Cited by 1
Bhasin, H., Agarwal, R., & Initiative, A. D. N. (2021) · Asia Conference on Computers and Communications (ACCC) · doi:10.1109/accc54619.2021.00031 · Cited by 1
Bhasin, H., Agrawal, R. K., & Initiative, A. D. N. (2021) · Asia Conference on Computers and Communications (ACCC) · doi:10.1109/accc54619.2021.00028 · Cited by 1
Cognitive assessment in primary care: Practical recommendations
Clevenger, C. K., Schlenger, A., Gunter, D. A., & Brewster, G. S. (2023) · The Nurse Practitioner · doi:10.1097/01.npr.0000000000000067 · Cited by 1
Dimension Reduction in the Sagittal Plane for Diagnosis of Mild Cognitive Impairment
Bhasin, H., Deshwal, V., & Jasuja, A. (2023) · Communications in computer and information science · doi:10.1007/978-3-031-35644-5_8 · Cited by 1
Vogrinc, D., Kramberger, M. G., Emeršič, A., Čučnik, S., Goričar, K., & Dolžan, V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241612966 · Cited by 1
“It is estimated that up to one-third of MCI patients develop dementia due to AD within five years [8].”
BackgroundGoodman, M., Li, X. R., Livschitz, J., Huang, C., Bendlin, B. B., Granadillo, E. D., & Initiative, A. D. N. (2023) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-230054 · Cited by 1
Unsupervised Anomaly Detection for Mild Cognitive Impairment Using Diffusion Model
Lei, Y., Nieuwoudt, M., Matsumoto, H., Zhong, N., Yin, P., & Wang, S. (2023) · Asia Conference on Cognitive Engineering and Intelligent Interaction (CEII) · doi:10.1109/ceii60565.2023.00016 · Cited by 1
“According to statistics, it has been observed that approximately one-third of individuals diagnosed with MCI will progress to AD within five years [3].”
BackgroundDoes Mild Functional Impairment Predict Dementia in Older Adults With Normal Cognition?
Zhang, L., Numbers, K. T., Brodaty, H., Lam, B. C. P., Mahalingam, G., & Reppermund, S. (2024) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000638 · Cited by 1
Ataka, T., Kimura, N., Kaneko, N., Masuda, T., Takeuchi, Y., Yabuuchi, K., Mizukami, T., Takeuchi, T., Ito, T., Tasai, H., et al. (2024) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.70008 · Cited by 3
Wang, S., Qi, Y., Jiang, Y., Chi, X., Huang, K., Ruan, C., Yang, X., & Li, G. (2021) · PubMed · doi:10.12122/j.issn.1673-4254.2021.07.19 · Cited by 2
Eye-Gaze and Mouse-Movements on Web Search as Indicators of Cognitive Impairment
Jacek Gwizdka, A., Tessmer, R., Chan, Y., Radhakrishnan, K., & Henry, M. L. (2022) · Lecture notes in information systems and organisation · doi:10.1007/978-3-031-13064-9_20 · Cited by 2
Luo, W., Hao, W., Ge, S., Tang, C., Liu, X., & Lu, L. (2021) · Research Square · doi:10.21203/rs.3.rs-517520/v1 · Cited by 1
Liappas, N. (2022) · UPM Digital Archive (Technical University of Madrid) · doi:10.20868/upm.thesis.72218
Tao, C., Lundin, S. K., Hu, X., Feng, J., Lundin, K., & Chen, Y. (2023) · Research Square · doi:10.21203/rs.3.rs-2629005/v1 · Cited by 1
“(Ward et al., 2013) Individuals with MCI are suggested to have 3 to 5 times higher likelihood to progress from MCI to any form of dementia compared to those with normal cognition.”
Kognitive Intervention bei leichter kognitiver Störung und Alzheimer-Demenz
Buschert, V. C. (2016) · Springer eBooks · doi:10.1007/978-3-662-50343-0_1
Dietary inflammatory index in patients with Alzheimer's dementia compared to controls
Halt, A. K. (2018) · MOspace Institutional Repository (University of Missouri) · doi:10.32469/10355/66321
Computer-based characterization of language alterations throughout the Alzheimer's disease continuum
Domínguez, H., & Elena, L. (2019)
Lopes, E. S. T. (2018) · Gredos (University of Salamanca) · doi:10.14201/gredos.139759
Complex anatomical patterns in mild cognitive impairment to Alzheimer’s disease conversion
Rincon, S., & Smith, S. K. (2019) · Cited by 1
Arias, J. A., Cadarso-Suárez, C., & Aguiar, P. (2021) · arXiv (Cornell University) · doi:10.48550/arxiv.2102.02908
“Future research should increase the number of participants and also increase the number of conditions considered by including transitional stages between healthy and AD populations such as patients suffering from MCI.”
BackgroundWorking memory binding: insights from neuroimaging, behavioural and clinical studies
Guazzo, F. (2020) · ERA · doi:10.7488/era/1294
Visual Attention-Related Processing: Perspectives from Ageing, Cognitive Decline and Dementia
Tales, A., & Hanley, C. (2021) · MDPI eBooks · doi:10.3390/books978-3-0365-0985-3
Folego, G. (2018) · doi:10.47749/t/unicamp.2018.1080338
Lim, H. J., Kim, M. Y., Shin, J. W., Lee, K. S., Youn, J. H., Park, B. M., Lee, J. H., & Kim, H. S. (2022) · Journal of the Korean Neurological Association · doi:10.17340/jkna.2022.1.4
Correia, R. D. C. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2021.tde-28012022-110238 · Cited by 2
Alzheimer’s Association Funding and Policy for Alzheimer’s Disease Drug Development
Carrillo, M. C., Meyers, E. A., & Snyder, H. M. (2022) · Cambridge University Press eBooks · doi:10.1017/9781108975759.044
Nielsen, J. E. (2021) · VBN Forskningsportal (Aalborg Universitet) · doi:10.54337/aau455017331
Cheng, J., Ji, X., Lu, H. E., ZHANG, Y., TongTong, X. I. A. O., Geng, Q., ZhiHui, W. A. N. G., Qi, S., Zhou, F., & Zhan, J. (2022) · Research Square · doi:10.21203/rs.3.rs-1690951/v1
Acute Coronary Syndrome in the Older Adult Populations
Rout, A., Hussain, S., & Damluji, A. A. (2022) · Contemporary cardiology · doi:10.1007/978-3-031-16594-8_10 · Cited by 1
Remote Ischemic Conditioning Alleviates Alzheimer’s Disease Pathology in Female TgF344 RatsPreprint
Ma, Y., Sun, W., Bai, J., Gao, F., Liu, H., Huang, Y., Hu, J., Xu, C., Ma, H., Yuan, T., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-2779541/v1
Wu, J.-N., Xia, H., Chen, N., Li, Y.-T., & Jiang, N. (2023) · doi:10.2196/preprints.49329
Imre, N. (2023) · SZTE Repository of Dissertations (University of Szeged) · doi:10.14232/phd.11496
Bhasin, H., Mehrotra, A., & Ohri, A. (2024) · Lecture notes in networks and systems · doi:10.1007/978-981-99-8451-0_8
Investigating the association between periodontal disease and Alzheimer's disease: a scoping reviewPreprint
Zhang, X., Chang, D., & Wu, Y. (2024) · Research Square · doi:10.21203/rs.3.rs-4199610/v1
Wolski, L., Bopp, A.-K., Schwientek, A.-K., Langer, S., Dogan, V., & Grimmer, T. (2024) · Zeitschrift für Gerontologie und Geriatrie · doi:10.1007/s00391-024-02319-y · Cited by 1
“So entwickeln 30–50% der Patient:innen mit einer MCI innerhalb von 5 bis 10 Jahren und bis zu 10% bereits innerhalb eines Jahres eine Demenz [17, 30 Den Gehirn-Check-up ( .”
Diploid Genetic Algorithm-Based Pipeline for the Conversion Prediction of Mild Cognitive Impairment
Bhasin, H., Kumar, A., & Deshwal, V. (2024) · IEEE Region 10 Symposium (TENSYMP) · doi:10.1109/tensymp61132.2024.10752147
“These patients are called MCI-Converts (MCI-C) and those who do not convert to dementia are referred to as MCI Non-Converts (MCI-NC) [32].”
Luo, Y., Su, B., Zheng, F., & Zheng, X. (2024) · Gerontology · doi:10.1159/000541150 · Cited by 1
Wenje, S., Calvert, S., Henshaw, H., Spriggs, R. V., Dening, T., Hendron, E., & Heffernan, E. (2024) · BMJ Open · doi:10.1136/bmjopen-2024-087418
Katz, A. J., Chang, P.-S., Gao, S., Apostolova, L. G., Passey, R. T., Yang, Z., Ceniza, D., & Lu, Y. Y.-F. (2025) · Contemporary Clinical Trials · doi:10.1016/j.cct.2025.107836
“Persons with cognitive impairment (PwCI) are at greater risk for developing dementia (10–33 % per year) relative to their cognitively unimpaired peers [4–6].”
Wang, X., Guo, Y., Chen, F., Liu, T., & Xie, X. (2025) · Neurocomputing · doi:10.1016/j.neucom.2025.130409
Bhasin, H., Deshwal, V., Kumar, N., Thakur, H. K., & Shankar, A. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5248394
Zhang, M., Rodriguez, A., Weir, R. L., Hanmer, J., Harrison, J. M., & Edelen, M. O. (2025) · Advances in Patient-Reported Outcomes · doi:10.1016/j.apro.2025.100190 · Cited by 1
“[5,6] Approximately 36 % of individuals with subjective cognitive decline develop MCI or dementia within 4 years [5], and 30 % of individuals with MCI develop Alzheimer’s disease or related dementias within five years [7].”
Qi, X., Sun, F., Yin, H., Zhang, X., Song, Y., Xu, G., & Bai, Y. (2025) · Geriatric Nursing · doi:10.1016/j.gerinurse.2025.103406
Guo, Z., Jiang, Y., He, J., & Jiang, N. (2025) · Science China Technological Sciences · doi:10.1007/s11431-025-2951-1 · Cited by 1
“A previous study reported that approximately 15% of individuals with MCI develop dementia after 2 years [5], and approximately one-third develop dementia caused by AD within 5 years [6].”
Long-term predictive accuracy of the ‘mild cognitive impairment due to Alzheimer's disease’ criteria
Cardoso, S., Montalvo, A., Marôco, J. P., Silva, D., Alves, L., Guerreiro, M., & de Mendonça, A. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251375927
Brain volumes discriminate clinical dementia rating scale categories
Christova, P. S., James, L. M., & Georgopoulos, A. P. (2025) · Scientific Reports · doi:10.1038/s41598-025-23418-9
“…documented that MCI, equivalent to CDR 0.5, is a notoriously heterogeneous group in which some will go on to develop dementia and others will not 6,64 structural MRI, particularly when coupled with the CDR or other similar measures, may be useful in identifying individuals with MCI who are…”
InfluentialLiu, Q., Huang, Y., Wang, B., & Wang, C. (2025) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.70184 · Cited by 1
Lazarjani, H. G., Zarei, S., Aboutorabi, F., Shalbaf, R., & Shalbaf, A. (2025) · Archives of Computational Methods in Engineering · doi:10.1007/s11831-025-10471-w · Cited by 4
Sun, R., Wang, Y., Xie, Y., Li, H., Pan, Z., Wu, B., Liu, X., & Wang, Y. (2025) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2025.106026
Hwang, E., Ham, H., Lee, D., Kim, H., Oh, S. H., Kang, J. G., Shim, S., Lee, S., Youn, J. H., & Lee, J. (2025) · Digital Health · doi:10.1177/20552076251406310
Li, G., Toschi, N., Devanarayan, V., Batrla, R., Boccato, T., Cho, M., Ferrante, M., Frech, F. H., Galvin, J. E., Henley, D. B., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24761409
Zhang, Q., Coury, R., & Tang, W. (2024) · Figshare · doi:10.6084/m9.figshare.26691178
Yang, T., Liu, W., He, J., Gui, C., Meng, L., Xu, L., & Jia, C. (2024) · Figshare · doi:10.6084/m9.figshare.26740217
Yang, T., Liu, W., He, J., Gui, C., Meng, L., Xu, L., & Jia, C. (2024) · Figshare · doi:10.6084/m9.figshare.26740220
Bi, S., Yan, S., Chen, Z., Cui, B., Shan, Y., Yang, H., Qi, Z., Zhao, Z., Han, Y., & Lu, J. (2024) · Figshare · doi:10.6084/m9.figshare.26672835
Gutiérrez-Tordera, L., Papandreou, C., Novau-Ferré, N., García‐González, P., Rojas, M., Marquié, M., Chapado, L. A., Papagiannopoulos, C., Fernàndez‐Castillo, N., Valero, S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26668371
Zhang, Q., Coury, R., & Tang, W. (2024) · Figshare · doi:10.6084/m9.figshare.26691181
Yang, T., Liu, W., He, J., Gui, C., Meng, L., Xu, L., & Jia, C. (2024) · Figshare · doi:10.6084/m9.figshare.26740223
Li, F., Yan, Y., Zheng, L., Wang, C., Guan, X., Hong, S., & Guo, H. (2023) · Figshare · doi:10.6084/m9.figshare.22610440
Gopalakrishna, G., Brunton, S., Pruzin, J. J., Alford, S., Hamersky, C. M., & Sabharwal, A. K. (2023) · Figshare · doi:10.6084/m9.figshare.24248097
Guzmán, D. T., Vivas, J. D. P., & Morales, E. B. (2025) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2025.108848
Zhu, Y., Yang, Y., Li, W., Shi, N., Wang, Y., Nan, J., Zhang, X., Han, L., & Ma, Y. (2026) · Neurological Sciences · doi:10.1007/s10072-025-08772-w
“Additionally, previous studies indicate that MCI is prone to progressing to dementia: among individuals with MCI, one analysis found that 14.9% of those over 65 developed dementia after 2 years [4], and another reported a 31.5% progression to Alzheimer’s dementia within 5 years [5].”
InfluentialAvances en el tratamiento de la enfermedad de Alzheimer
Segura, J. M. G. (2026) · FMC - Formación Médica Continuada en Atención Primaria · doi:10.1016/j.fmc.2025.08.001
Metadata
- Authors
- Ward, A., Tardiff, S., Dye, C., & Arrighi, H. M.
- Affiliations
- Janssen Alzheimer Immunotherapy Research & Development (United States) (US)
- Corresponding author
- Arrighi, H. Michael
- ORCID
- Ward, Alex
- Venue
- Dementia and Geriatric Cognitive Disorders Extra
- Publisher
- S. Karger AG
- Published
- 2013-09-28
- Volume
- 3
- Issue
- 1
- Pages
- 320-332
- ISSN
- 1664-5464 (ISSN-L)
- PMC
- PMC3808216
- OpenAlex
- W2010643121
- Cited by
- 426
- References
- 68
- Citations by year
- 2026: 28 · 2025: 47 · 2024: 64 · 2023: 61 · 2022: 44 · 2021: 60 · 2020: 32 · 2019: 30 · 2018: 26 · 2017: 5 · 2016: 14 · 2015: 11 · 2014: 4
- FWCI
- 1.32
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- creativecommons.org/licenses/by-nc/3.0/ (vor)
- creativecommons.org/licenses/by-nc/3.0/ (tdm)
- Locations
- Dementia and Geriatric Cognitive Disorders Extra (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
- Keywords
- prodromal Alzheimer's disease, Alzheimer's dementia, conversion rate, mild cognitive impairment, amnestic mild cognitive impairment, cohort studies, loss to follow-up, diagnostic criteria
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
